We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A report on the use of dual NAATs for chlamydia and gonorrhoea on samples collected for the National Chlamydia Screening Programme (NCSP).
How to use A/B testing to evaluate your digital health product.
Guidance to assist staff involved with the collection, recording, analysis and interpretation of data from CTAD and GUMCAD.
How to use feedback from marketplace reviews to evaluate your digital health product.
This document (PHE-CRCE-012) quantifies the performance of an array of germanium detectors.
SDU provides advice on serological assay development.
Genome sequencing, transcription and proteogenome analysis, pathogen discovery and metagenomics.
A list of all Rapid Review Panel (RRP) decisions on products.
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
A joint guidance statement from the Committees on carcinogenicity, on toxicity, and on mutagenicity of chemicals in food, consumer products and the environment (COC, COT, COM).
Information for elected members on the National Child Measurement Programme (NCMP) including local authority case studies.
An assessment on the potential population impact of proposed changes to the children’s epilepsy surgery service (CESS) specification.
Privacy notices for participants in the Vivaldi study.
An overview of workshops held to connect public health professionals by the Research Translation and Innovation division across PHE centres.
How to begin with evaluating a digital health product, including when to evaluate, budgeting and getting support.
Why it's important to evaluate digital health products that have been developed rapidly and how to choose evaluation methods in these circumstances.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).